Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells
about
Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesisRibavirin enhances interferon signaling via stimulation of mTOR and p53 activitiesCounteracting Quasispecies Adaptability: Extinction of a Ribavirin-Resistant Virus Mutant by an Alternative Mutagenic TreatmentCombinations of 2'-C-methylcytidine analogues with interferon-alpha2b and triple combination with ribavirin in the hepatitis C virus replicon systemMutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing MutationsPotential benefits of sequential inhibitor-mutagen treatments of RNA virus infectionsCell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirinGene expression signature-based screening identifies new broadly effective influenza a antiviralsHepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response.Ribavirin improves early responses to peginterferon through improved interferon signalingRibavirin enhances IFN-α signalling and MxA expression: a novel immune modulation mechanism during treatment of HCV.Gene expression differences in lungs of mice during secondary immune responses to respiratory syncytial virus infection.Animal pneumoviruses: molecular genetics and pathogenesis.Ribavirin enhances the action of interferon-α against hepatitis C virus by promoting the p53 activity through the ERK1/2 pathwayHigh-throughput screening normalized to biological response: application to antiviral drug discovery.Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features.Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivoRibavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infection.Host transcription profiles upon primary respiratory syncytial virus infectionIn search of a small-molecule inhibitor for respiratory syncytial virus.Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections.Insights into host responses against pathogens from transcriptional profiling.Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir.Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture modelsEpimedium koreanum Nakai Water Extract Exhibits Antiviral Activity against Porcine Epidermic Diarrhea Virus In Vitro and In VivoAssociation of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.Ribavirin in the treatment of chronic hepatitis C.Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: a phase II studyAntigen-specific gene expression profiles of peripheral blood mononuclear cells do not reflect those of T-lymphocyte subsets.Mechanism of action of ribavirin in the treatment of chronic hepatitis C.Systems biology unravels interferon responses to respiratory virus infections.Respiratory syncytial virus inhibits lung epithelial Na+ channels by up-regulating inducible nitric-oxide synthase.Leishmania major abrogates gamma interferon-induced gene expression in human macrophages from a global perspective.Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells.Reactive oxygen species mediate virus-induced STAT activation: role of tyrosine phosphatases.Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes.Coevolution of the hepatitis C virus polyprotein sites in patients on combined pegylated interferon and ribavirin therapy.Respiratory syncytial virus influences NF-kappaB-dependent gene expression through a novel pathway involving MAP3K14/NIK expression and nuclear complex formation with NF-kappaB2.Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization.Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C.
P2860
Q21132564-52F83EBF-6030-4B00-86CE-57F36CD8EF54Q24316273-40091549-6A7D-4C13-B467-582F0FEC9227Q27488361-BC466AEF-A6D8-44AC-B42E-A15192B6EB9AQ27489596-94DD0438-EC5C-483A-83B5-20BF4B021E2CQ28072953-B6985811-BDEB-4458-989A-0D4E3FED6DC3Q28471847-0335043D-BC76-4E75-B013-8530312074E8Q28474617-5F593B61-FD66-486E-A121-9765D8CB62FEQ28475681-86737FF1-A4E4-4E9F-8688-02A194DBCB7FQ33597579-BA354196-983C-47C9-8386-15B16363CB1CQ33987120-EBBE6E64-A148-4170-8063-835C16DE0C3DQ34082923-DDB3A708-BC12-488D-BE8A-1FF785E52054Q34120191-957F4FCF-EE9B-444A-A898-F8577B75414DQ34313560-37ECC01F-6833-4236-A063-3FE90B3872CFQ34409751-8652B4E0-DD41-495F-99A6-23668C94A31DQ34824028-3D0D8433-690F-421D-9CD2-C1512A75AC9CQ34866372-45876923-91DF-4A45-8D9F-8ACF81EE02F4Q35701867-265C01C8-365F-4B1E-954F-E57B416803CAQ35748913-5392D406-0311-438E-8597-15DE6FDE9EB1Q35857662-BC02B8A9-9544-4B97-B940-85F9822FA477Q35917503-C02F3D67-2F1F-4241-B3EA-715D79EBA525Q36073739-E535BFBD-1C41-42CD-B3B3-DFCA05184E64Q36087019-E48F09A3-80D2-495D-AA7F-57EDB7DB0736Q36166222-F31CD382-B286-43DB-988D-58991EEF1AEFQ36399860-208E7A20-2CCE-469E-BC2E-C9ED1287BEF8Q36464386-9C46451B-B821-48BE-8475-DEB60917D2B9Q37028594-FB9DF78A-F10B-41BD-B25E-A239C117BD6DQ37195248-6FC46CCD-A1A9-42B5-833C-1D0DF33ED440Q37481103-DD89ED41-DC4B-4963-97C0-E1D4105800F9Q37495165-E8841142-9B1F-4592-9988-6CCA24F23ACDQ37940977-480C04BB-E708-4F86-82C8-DD8522E5806AQ38193816-BF88E829-B625-4F53-86B9-2B8D678637C2Q39897567-D082E195-D4E9-4ECA-BB55-18DBE1BABD30Q40139059-8790785B-6187-464C-B2A1-4CD4C325FBE9Q40208138-BFEE8C97-0872-428C-AE0F-A1BAB0E10A48Q40623094-8B805E31-2A02-488E-AFCC-CED69C7FAC8CQ41156164-43A9E33D-FFE7-45F8-9237-F9C70D7679CAQ41841986-32197B8C-A707-47CB-B673-CCC4BA068234Q42040589-9B93CC51-F076-4CC9-968A-57385236E574Q45397299-985CFB1E-DC05-452F-BC07-24D2514CE8BCQ50568686-C2394774-D8F7-4462-BBB8-5A31D52E22C5
P2860
Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Ribavirin treatment up-regulat ...... irus-infected epithelial cells
@ast
Ribavirin treatment up-regulat ...... irus-infected epithelial cells
@en
Ribavirin treatment up-regulat ...... irus-infected epithelial cells
@nl
type
label
Ribavirin treatment up-regulat ...... irus-infected epithelial cells
@ast
Ribavirin treatment up-regulat ...... irus-infected epithelial cells
@en
Ribavirin treatment up-regulat ...... irus-infected epithelial cells
@nl
prefLabel
Ribavirin treatment up-regulat ...... irus-infected epithelial cells
@ast
Ribavirin treatment up-regulat ...... irus-infected epithelial cells
@en
Ribavirin treatment up-regulat ...... irus-infected epithelial cells
@nl
P2093
P2860
P1433
P1476
Ribavirin treatment up-regulat ...... irus-infected epithelial cells
@en
P2093
Antonella Casola
Mohammad Jamaluddin
Roberto P Garofalo
Shaofei Wang
Yuhong Zhang
P2860
P304
P356
10.1128/JVI.77.10.5933-5947.2003
P407
P577
2003-05-01T00:00:00Z